We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.55%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.63B
AUM Growth
-$332M
(-11%)
Cap. Flow
-$165M
Cap. Flow
% of AUM
-6.27%
Top 10 Holdings %
Top 10 Hldgs %
27.16%
Holding
459
New
61
Increased
86
Reduced
158
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$32.4M |
| 2 |
FL
Foot Locker
FL
|
+$31.9M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$30.7M |
| 4 |
Nike
NKE
|
+$24.8M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$23.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DST
DST Systems Inc.
DST
|
+$64.8M |
| 2 |
Walt Disney
DIS
|
+$40.4M |
| 3 |
STRZA
Starz - Series A
STRZA
|
+$38.6M |
| 4 |
United Therapeutics
UTHR
|
+$24.4M |
| 5 |
SWI
SOLARWINDS INC COM STK (DE)
SWI
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Consumer Discretionary | 17.69% |
| 3 | Technology | 17.25% |
| 4 | Industrials | 12.49% |
| 5 | Consumer Staples | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XCRA
151
DELISTED
Xcerra Corporation
XCRA
| $1.89M | 0.07% |
301,280
-70
| -0% | -$448 |
|
152
The Greenbrier Companies
GBX
$1.43B
| $1.87M | 0.07% |
58,167
-50
| -0.1% | -$2.1K |
|
153
Interparfums
IPAR
$3.83B
| $1.72M | 0.07% |
69,450
-19
| -0% | -$539 |
|
|
TVRD
154
Tvardi Therapeutics
TVRD
$22M
| $1.63M | 0.06% |
3,170
-1
| -0% | -$669 |
|
|
AFFX
155
DELISTED
Affymetrix Inc
AFFX
| $1.57M | 0.06% |
183,930
+1,640
| +0.9% | +$16.4K |
|
|
FOLD
156
DELISTED
Amicus Therapeutics
FOLD
| $1.48M | 0.06% |
105,780
-32,750
| -24% | -$514K |
|
|
SYNH
157
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.45M | 0.05% |
36,151
+35,450
| +5,057% | +$1.55M |
|
158
Citi Trends
CTRN
$618M
| $1.4M | 0.05% |
59,940
+55,761
| +1,334% | +$1.37M |
|
159
Cytokinetics
CYTK
$10.5B
| $1.18M | 0.05% |
177,010
+170,570
| +2,649% | +$1.16M |
|
|
SRDX
160
DELISTED
Surmodics
SRDX
| $1.14M | 0.04% |
51,990
-10
| -0% | -$235 |
|
161
Build-A-Bear
BBW
$467M
| $1.12M | 0.04% |
59,210
-101,900
| -63% | -$1.93M |
|
|
ADMS
162
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.1M | 0.04% |
65,640
-10
| -0% | -$228 |
|
|
TRVN
163
DELISTED
Trevena, Inc.
TRVN
| $1.07M | 0.04% |
+165
| New | +$815K |
|
164
Exelixis
EXEL
$13.1B
| $1.05M | 0.04% |
+186,870
| New | +$1.02M |
|
|
ACHN
165
DELISTED
Achillion Pharmaceuticals
ACHN
| $978K | 0.04% |
+141,510
| New | +$1.15M |
|
|
DYAX
166
DELISTED
DYAX CORPORATION
DYAX
| $958K | 0.04% |
+50,180
| New | +$1.2M |
|
|
KYNB
167
Kyntra Bio
KYNB
$28.2M
| $928K | 0.04% |
+1,693
| New | +$1.03M |
|
|
MNTA
168
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $904K | 0.03% |
+55,100
| New | +$1.13M |
|
|
PGNX
169
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $893K | 0.03% |
+156,060
| New | +$1.2M |
|
|
CDMO
170
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $888K | 0.03% |
124,360
-33
| -0% | -$275 |
|
|
TESO
171
DELISTED
Tesco Corp
TESO
| $881K | 0.03% |
123,340
-30
| -0% | -$259 |
|
|
NTUS
172
DELISTED
Natus Medical Inc
NTUS
| $871K | 0.03% |
22,080
| – | – |
|
173
Inovio Pharmaceuticals
INO
$76.1M
| $867K | 0.03% |
12,494
-3
| -0% | -$261 |
|
174
BGC Group
BGC
$4.86B
| $830K | 0.03% |
156,993
-31
| -0% | -$180 |
|
175
Opko Health
OPK
$1.04B
| $820K | 0.03% |
97,550
-20
| -0% | -$265 |
|
Similar funds
M
GWM
QT
SCM
TW
KFA
SG
FFA
Smith Group Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Smith Group Asset Management held 459 positions worth $2.63B, down 11% from $2.97B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Smith Group Asset Management withdrew a net $165M in Q3 2015, closing 50 positions and reducing 158 holdings. Its most notable exit was DST Systems Inc., an estimated $64.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Smith Group Asset Management opened a new position in Citrix Systems Inc worth $31.4M.
- Smith Group Asset Management's largest Q3 2015 buy was Citrix Systems Inc: 569,631 shares worth $31.4M.
- Smith Group Asset Management added most to Foot Locker in Q3 2015, an estimated $31.9M increase.
- Smith Group Asset Management's biggest Q3 2015 reduction was United Therapeutics, cutting an estimated $24.4M.
- Smith Group Asset Management fully exited DST Systems Inc. in Q3 2015, selling an estimated $64.8M.
- Smith Group Asset Management's ten largest holdings make up 27% of its $2.63B portfolio in Q3 2015.
- Smith Group Asset Management opened 61 new positions and closed 50 in Q3 2015.
- Smith Group Asset Management's portfolio value fell 11% quarter-over-quarter to $2.63B.
Based on Smith Group Asset Management's 13F filing for Q3 2015, filed 23 Oct 2015.